183 related articles for article (PubMed ID: 10679281)
1. Selective activation of antitumor activity of macrophages by the delivery of muramyl dipeptide using a novel polynucleotide-based carrier recognized by scavenger receptors.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
Biochem Biophys Res Commun; 2000 Feb; 268(3):772-7. PubMed ID: 10679281
[TBL] [Abstract][Full Text] [Related]
2. Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
J Leukoc Biol; 2000 May; 67(5):683-90. PubMed ID: 10811009
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
Petit C; Monsigny M; Roche AC
J Biol Response Mod; 1990 Feb; 9(1):33-43. PubMed ID: 2319259
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
5. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
Reisser D; Jeannin JF; Martin F
C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
7. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
[TBL] [Abstract][Full Text] [Related]
8. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
9. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
Reisser D; Jeannin JF; Lagadec P; Martin F
J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
[TBL] [Abstract][Full Text] [Related]
10. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
11. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
[TBL] [Abstract][Full Text] [Related]
12. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
14. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
Phillips NC; Moras ML; Chedid L; Petit JF; Tenu JP; Lederer E; Bernard JM; Lefrancier P
J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756
[TBL] [Abstract][Full Text] [Related]
15. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing.
Zhang L; Zhu H; Lun Y; Yan D; Yu L; Du B; Zhu X
Cell Mol Immunol; 2007 Oct; 4(5):359-67. PubMed ID: 17976316
[TBL] [Abstract][Full Text] [Related]
17. Induction of intracellular cytokine production in human monocytes/macrophages stimulated with ligands of pattern recognition receptors.
Mytar B; Gawlicka M; Szatanek R; Wołoszyn M; Ruggiero I; Piekarska B; Zembala M
Inflamm Res; 2004 Mar; 53(3):100-6. PubMed ID: 15021964
[TBL] [Abstract][Full Text] [Related]
18. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
19. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
20. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
